In this study, the mechanism of OX 1 orexin receptors to regulate adenylyl cyclase activity when recombinantly expressed in Chinese hamster ovary cells was investigated. In intact cells, stimulation with orexin-A led to two responses, a weak (21%), high potency (EC 50 Ϸ 1 nM) inhibition and a strong (4-fold), low potency (EC 50 ‫؍‬ Ϸ300 nM) stimulation. The inhibition was reversed by pertussis toxin, suggesting the involvement of G i/o proteins. Orexin-B was, surprisingly, almost equally as potent as orexin-A in elevating cAMP (pEC 50 ‫؍‬ Ϸ500 nM). cAMP elevation was not caused by Ca 2؉ elevation or by G␤␥. In contrast, it relied in part on a novel protein kinase C (PKC) isoform, PKC␦, as determined using pharmacological inhibitors. Yet, PKC stimulation alone only very weakly stimulated cAMP production (1.1-fold). In the presence of G s activity, orexins still elevated cAMP; however, the potencies were greatly increased (EC 50 of orexin-A ‫؍‬ Ϸ10 nM and EC 50 of orexin-B ‫؍‬ Ϸ100 nM), and the response was fully dependent on PKC␦. In permeabilized cells, only a PKC-independent low potency component was seen. This component was sensitive to anti-G␣ s antibodies. We conclude that OX 1 receptors stimulate adenylyl cyclase via a low potency G s coupling and a high potency phospholipase C 3 PKC coupling. The former or some exogenous G s activation is essentially required for the PKC to significantly activate adenylyl cyclase. The results also suggest that orexin-B-activated OX 1 receptors couple to G s almost as efficiently as the orexin-A-activated receptors, in contrast to Ca 2؉ elevation and phospholipase C activation, for which orexin-A is 10-fold more potent.
The neuropeptides/hormones orexin-A and -B and the corresponding G-protein-coupled receptors OX 1 and OX 2 receptor were discovered in 1998 (1, 2) . Orexin-A (33 amino acids) and orexin-B (28 amino acids) share the property of being able to activate both orexin receptors. Orexins are signal substances both in the central nervous system and in the periphery. In the central nervous system, all of the orexinergic neurons have their origin in the lateral hypothalamus from where they project widely to regulate especially wakefulness and paradoxical sleep, appetite and food intake, and endocrine and autonomic processes. At most of the projection sites both OX 1 and OX 2 receptors are expressed. The orexins most often act in an excitatory manner both via putative pre-, post-, and extrasynaptic mechanisms. In the periphery, orexins and orexin receptors have been have been found in the gastrointestinal tract and in the endocrine organs. The prominent periferal effects seen so far include regulation of gastrointestinal motility and hormone production and release, especially in the adrenal gland (reviewed in Ref. 3) .
Based on measurements of binding affinity and the ability to elevate intracellular Ca 2ϩ and liberate inositol phosphates in heterologous expression systems, the OX 1 receptor shows a 10-fold preference for orexin-A over orexin-B in contrast to the OX 2 receptor, which shows no preference (2, 4 -8) . This postulated selectivity profile is often used to determine the involved orexin receptor subtype in native cells and in vivo. However, some doubt has been cast on the validity of this practice. It is well known that different G-protein pathways can be differentially activated by different receptor agonists via agonist-selective receptor conformations (9) , and a similar process has even been suggested for orexin receptors (7) . Therefore, functional selectivity of receptor agonists may not be valid for all systems and responses.
The cellular signals triggered upon orexin receptor activation are relatively unclear. OX 2 receptors have been shown to be able to activate G i , G q , and G s proteins (10) , but the efficacy of the interaction and the role of these in the orexin receptor signaling is unknown. Some other studies, by the use of pertussis toxin or other techniques, suggest that G i/o proteins are engaged in orexin signaling (8, (11) (12) (13) . On the other hand, most other responses seen in native cells and cell lines, e.g. Ca 2ϩ elevation, phospholipase C (PLC) 1 activation, and activation of cation channels, are unlikely to be mediated by G i/o proteins. Ca 2ϩ elevation is a prominent response seen in all the cell lines where the receptors have been heterologously expressed (2, 6, 8, 14) and in all the native neurons where this has been investigated (15) (16) (17) (18) (19) . Two different mechanisms seem to be active: (i) Ca 2ϩ influx via a non-voltage-gated pathway in recombinant cells (14, 20) and via voltage-gated Ca 2ϩ channels in neurons 1 The abbreviations used are: PLC, phospholipase C; AC, adenylyl cyclase; CTx, cholera toxin; GF109203X, bisindolylmaleimide I (or Gö6850), 2-(1- and some endocrine cells (17-19, 21, 22) and (ii) PLC activation and inositol 1,4,5-trisphosphate-dependent Ca 2ϩ release (4, 7, 10, 14, (23) (24) (25) . Both orexin receptor subtypes seem to share these pathways. Ca 2ϩ elevation could well explain some of the excitatory properties of orexin. Activation of adenylyl cyclase has also been shown to be important for orexin receptor signaling, although this pathway has seldom been investigated. In rat and human adrenal cortex, orexins strongly elevate cAMP, leading to activation of protein kinase A and increased synthesis and release of glucocorticoids (26, 27) , probably, at least in man, via OX 1 receptors (27) . Although this effect appears to be very similar to the adrenocorticotropic hormone, which utilizes the G s pathway, the mechanisms of orexin signaling to adenylyl cyclase has not been investigated.
cAMP is a ubiquitous second messenger involved in a vast array of physiological processes such as regulation of glycogen metabolism, regulation of hormone synthesis, modulation of ion channels, and regulation of gene transcription. Most of these effects are mediated through binding and activation of protein kinase A, but novel targets of cAMP, such as Epacs, guanine nucleotide exchange factors of the small G-protein Rap, have been identified recently (28) . Adenylyl cyclases (AC) are the enzymes responsible for cAMP production. Membranebound adenylyl cyclases with nine known mammalian isoforms are subject to many positive and negative regulatory inputs from especially G-protein-coupled receptors but also from other pathways (reviewed in Refs. 29 and 30) . The most important (known) inputs include G-protein ␣-subunits (G␣ i/o , G␣ s ), Gprotein ␤␥-subunits (G␤␥), Ca 2ϩ /calmodulin, and protein kinase C (PKC). Three features are characteristic: (i) each isoform responds to a different subset of these factors; (ii) for one isoform a particular factor can be inhibitory, whereas it can be stimulatory for another isoform; and (iii) the factors can show strong cooperativity or even conditionality for stimulation of adenylyl cyclase. Thus, for instance, G␤␥ can inhibit AC1, whereas it stimulates AC2, AC4, and AC7. However, it cannot stimulate AC2 (and probably neither AC4 nor AC7) unless the AC is simultaneously stimulated by other factors (e.g. G␣ s or PKC) (31, 32) . The consequence of this isoform-specific signal integration is that the cAMP response will differ from cell to cell according to the expression profile of adenylyl cyclase isoforms as well as other proteins participating in the adenylyl cyclase regulation.
Recognizing the important role of cAMP in cellular processes and its putative importance of orexin receptor signaling, we wanted to investigate the intrinsic ability of OX 1 orexin receptors to regulate adenylyl cyclase activity in an isolated system, where manipulations are possible. For this purpose we chose a Chinese hamster ovary (CHO) cell line recombinantly expressing OX 1 receptors. This cell line has two advantages: (i) orexin receptor signaling in it has been relatively well characterized in previous studies by us and others (2, 4, 14, 20, 33) and (ii) it does not appear to express Ca 2ϩ -sensitive adenylyl cyclase isoforms, minimizing interference from this strong signal of orexin receptors.
EXPERIMENTAL PROCEDURES
Cell Culture-CHO-hOX 1 cells, as described before (14) , were cultured in nutrient mixture (Ham's F-12) medium (Invitrogen) supplemented with 10% heat-inactivated fetal calf serum (Invitrogen), 100 units/ml penicillin (Sigma), 80 units/ml streptomycin (Sigma), and 400 g/ml geneticin (G418; Invitrogen) in an air-ventilated humidified incubator in 260-ml plastic culture flasks (75-cm 2 bottom area; Greiner Bio-One GmbH, Frickenhausen, Germany). For microfluorometry and Ca 2ϩ measurements, the cells were grown on uncoated circular glass coverslips (diameter, 25 mm; Menzel-Glä ser, Braunschweig, Germany) and for other experiments on circular plastic culture dishes (inner diameter, 52 or 82 mm; Greiner). When the effect of pertussis toxin pretreatment was investigated, the cells were treated with 100 ng/ml pertussis toxin for 24 -48 h. For cholera toxin, different concentrations (10, 100, and 1000 ng/ml) for 18 h were initially tested (see Fig. 4) ; subsequent experiments were then performed using 10 ng/ml for 18 h.
Chemicals-Cholera toxin (CTx), GF109203X (bisindolylmaleimide 3 , 10 mM glucose, and 20 mM TES adjusted to pH 7.4 with NaOH. Lysis buffer was composed of 50 mM HEPES and 150 mM NaCl (pH.7.5) supplemented with 10% (v/v) glycerol, 1% (v/v) Triton X-100, 1.5 mM MgCl 2 , 1 mM EDTA, 10 mM Na ϩ -pyrophosphate, 1 mM Na ϩ -orthovanadate, 10 mM Na ϩ -fluoride, 250 M p-nitrophenol phosphate, 10 g/ml aprotinin, 10 g/ml leupeptin, and 1 mM phenylmethylsulfonyl fluoride. Laemmli sample buffer was composed of 50 mM Tris-HCl (pH 6.8) supplemented with 1 mM dithiothreitol, 2% SDS (w/v), 10% glycerol (v/v), and 0.1% bromphenol blue (w/v).
Expression Vectors-pcDNA3.1 plasmids harboring human ␤ 2 -adrenoreceptor, human transducin (G␣ t-rod ), human G␤ 1 , and human G␥ 2 were from the Guthrie cDNA Resource Center (www.cdna.org). The plasmid for expression of enhanced green fluorescent proteins (GFP), pEGFP-C1, was from Clontech (Palo Alto, CA). We gratefully acknowledge Dr. Robert J. Lefkowitz (Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC) for pRK5-␤ARK1-CT (C terminus of the human ␤-adrenergic receptor kinase 1 (␤ARK1)), Dr. J. Silvio Gutkind (NIDCR, National Institutes of Health, Bethesda, MD) for pcDNAIII T8-␤ ARK (a fusion of the extracellular and transmembrane part of CD8 and the C terminus of the human ␤ARK1), and Dr. Johanna Ivaska (VTT Medical Biotechnology, Centre for Biotechnology, Turku, Finland) for pEGFP-C1-PKC⑀wt (fusion of GFP and PKC⑀) (37) .
Transfection-CHO-OX 1 cells were grown on plastic culture dishes or on glass coverslips to 40 -50% confluence. The dishes were washed with PBS, and the cells were transfected in OPTI-MEM (Invitrogen) using Lipofectamine (Invitrogen). After 5 h this medium was replaced with fresh Ham's F-12 medium with all of the usual supplements (see "Cell Culture"). Transfection efficiency was 40 -70% as determined using expression of green fluorescent protein and function of transfected proteins (e.g. receptors, phosphodiestarases; not shown). Transfection of the cells was performed to introduce control receptors (␤ 2 -adrenoreceptor for G s coupling and ␣ 2A -adrenoreceptor for G␤␥-dependent PLC activation (and Ca 2ϩ release)), G␤␥ sequestering peptides/proteins (␤ARK1 C terminus, CD8-␤ARK1 C terminus, G␣ t ), and GFP-PKC constructs. The total amount of DNA was kept the same in all of the transfections using empty plasmids.
Measurement of cAMP Production in Intact Cells-The cellular ATP was prelabeled with 5 Ci/ml [ 3 H]adenine for 2 h in culture medium, after which the cells were detached using PBS ϩ 0.02% (w/v) EDTA, washed, and incubated at 37°C in TBM containing 500 M 3-isobutyl-1-methylxanthine, a phosphodiesterase inhibitor, for 10 min (38) . Thereafter the cells were stimulated for 10 min at 37°C, after which the reactions were interrupted by centrifugation, removal of the supernatant, addition of perchloric acid, and freezing. Measurement of Adenylyl Cyclase Activity in Permeabilized CellsUnlabeled cells were detached, washed in TBM, suspended in 50 mM Tris-HCl, 10 mM MgCl 2 , and 1 mM EDTA (pH 7.6), and permeabilized with 10 g/ml digitonin. After this they were diluted in 4 volumes of 25 mM Tris-HCl, 100 mM NaCl, 2.5 mM MgCl 2 , 25 mM cAMP, 25 M GTP, 100 M ATP, 0.8 mg/ml creatine phosphokinase, and 5 mM phosphocreatine (pH 7.6). When the effect of anti-G␣ s IgG was assessed, permeabilized cells in a minimal volume were incubated with a 1:10 dilution of the antibody for 2 h on ice before diluting in the experimental buffer. The aliquots used as controls were similarly incubated on ice; however, incubation on ice itself only slightly reduced the responses. The reactions were carried out for 15 min at 30°C in the presence of 0.24 M [ 33 P]ATP (ϳ100 000 cpm). The reactions were interrupted by the addition of perchloric acid. Dowex/alumina separation was carried out as above except that the [ 14 C]cAMP tracer was not included. Ca 2ϩ Measurements-Ca 2ϩ imaging was performed to evaluate the effectivity of the different G␤␥-sequestering peptides (␤ARK1 C terminus, CD8-␤ARK1 C terminus, G␣ t ). A clear G␤␥-mediated response, ␣ 2A -adrenoreceptor-induced Ca 2ϩ elevation, was selected as the test. This was verified using pertussis toxin, which fully inhibited this signal but not the endogenous P2Y-purinoceptor response. The cells were transfected with GFP, ␣ 2A -adrenoreceptor, and each G␤␥ scavenger or empty vector (DNA ratio 1:2:7) as described above. 48 h later, the cells on coverslips were loaded with 4 M fura-2 for 20 min at 37°C in TBM ϩ 0.5 mM probenecid (an inhibitor of the anion pump, which otherwise effectively extrudes fura-2), rinsed once, and used immediately. TILLvisION version 4.01 imaging system (TILL Photonics GmbH, Grä felding, Germany) was used for the measurements (39) . The cells were excited by alternating 340-and 380-nm light with the use of a monochromator, and the emission light was collected through a dichroic mirror and a 475-nm barrier filter with a CCD camera. The coverslips were constantly perfused at a rate of 1 ml/min in a ϳ160-l perfusion chamber at 37°C. The additions into the chamber were made by perfusion. The data were analyzed using the TILL software and Microsoft Excel.
Inositol Phosphate Measurements-The cells were prelabeled with 3 mCi/ml myo-[
3 H]inositol for 20 h (14), after which they were harvested as for cAMP measurements in intact cells. The cells were preincubated at 37°C in TBM containing 10 mM LiCl for 10 min, after which they were stimulated for 20 min. The reactions were terminated by spinning, replacement of TBM with ice-cold perchloric acid, and freezing. The supernatants were neutralized with KOH ϩ KHCO 3 , and the total inositol phosphate fraction was isolated with Dowex anion exchange chromatography. Radioactivity was determined using scintillation counting.
Translocation of GFP Fusion Proteins-CHO cells were transfected with the plasmid coding for GFP-PKC⑀ (pEGFP-C1-PKC⑀wt) as described above. The experiments were performed 24 later. The experiments were performed essentially as Ca 2ϩ measurements, except that 490-nm light was used for excitation, and the emission was collected through 505-nm dichroic mirror and 520-nm barrier filter. 100ϫ/1.3 oil immersion objective was used for measurements (39) .
SDS-PAGE and Immunoblotting-Cells on plastic culture dishes were washed once with ice-cold PBS and lysed then with lysis buffer (100 l/85-mm dish). The protein concentration was quantified using DC protein assay (Bio-Rad) and adjusted accordingly. Volumes corresponding to 20 g of protein were diluted in Laemmli buffer, boiled, separated by SDS-PAGE (10% acrylamide), and transferred to methanol-soaked polyvinylidene difluoride membranes (Amersham Biosciences). The membranes were blocked with 0.1% (v/v) Tween 20 and 5% (w/v) milk in PBS (TPBS-milk) for 1-2 h in room temperature before probing with antisera. Primary antibody incubation was done in TPBS at ϩ4°C overnight, and secondary antibody incubation was done in TPBS-milk at room temperature for 1 h after two 20-min washes with TPBS.
Specific protein detection was performed using rabbit polyclonal anti-PKC␦ (SC-213), -⑀ (SC-214), -(SC-215), and -(SC-210) antibodies (1:500; St. Cruz Biotechnology, Santa Cruz, CA). Primary antibodies were detected using horseradish peroxidase-conjugated donkey antirabbit antibody F(abЈ)2 fragments (1:2000; Amersham Biosciences). Peroxidase enzymatic activity was visualized using the Enhanced Chemiluminescence assay (Amersham Biosciences). After this, the membranes were washed for 2 h with TPBS-milk, and the actin in each lane was probed for using rabbit polyclonal anti-actin antibody (A2066; 1:1000; Sigma) and the same secondary antibody as above. Same detection system was used as above. The densities of the exposed films were quantified using a "homemade" system described in Ref. 40 . The system was calibrated using films of known densities (Wratten ND 0.1, 0.3, 0.5, 0.7, and 1) as described in Ref. 40 , and the absorbances of the lanes were always kept in the range of 0.1-1. The controls, which the data were to be compared with, were always run on the same gel.
Data Analysis-Student's two-tailed t test was used in all pairwise comparisons and analysis of variance, followed by Tukey's post-hoc test, for multiple comparisons. In most cases, there was some variation in the basal and stimulated cAMP levels in different batches of cells, and the data were therefore normalized to the basal/control level to allow reliable comparison (see e.g. Fig. 2 ). The significances are as follows: not significant (ns), p Ͼ 0.05; p Ͻ 0.05 (*); p Ͻ 0.01 (**); and p Ͻ 0.001 (***). Any second comparison is marked with ns and †. Significances are indicated only for the data where the results are not self-evident. In the figures, the mean Ϯ S.E. is given. Each experiment was performed at least three times. SigmaPlot 4.1 (Jandel Scientific, Corte Madera, CA) was used for nonlinear curve fitting. 1 Receptors to Adenylyl Cyclase-OX 1 receptors strongly elevate cAMP upon stimulation with orexin-A (4.3 Ϯ 0.5-fold, number of independent measurements ϭ 17; Fig. 1 ). This effect was fully reversed by the OX 1 receptor antagonist SB-334867 (Fig. 1) . The basal properties of the adenylyl cyclase expressed in CHO cells were therefore investigated to clarify the possible pathways used by the OX 1 receptors. Known stimulators of adenylyl cyclase include G␣ s , G-protein ␤␥-subunits, Ca 2ϩ , and PKC (see Introduction). Each agent may act on its own, but additive or synergistic effects are often seen. In addition, especially G␤␥ stimulation often requires some other stimuli, e.g. G␣ s . To assess the influence of each of these regulatory inputs, different methods to manipulate them were devised. The effect of elevated intracellular Ca 2ϩ level was investigated using the sarco-endoplasmic reticulum Ca 2ϩ ATPase inhibitor thapsigargin, which causes a moderate Ca 2ϩ elevation via emptying of the endoplasmic reticulum and permanent activation of the store-operated Ca 2ϩ influx, and ionomycin, which, by being a Ca 2ϩ ionophore, causes a very large Ca 2ϩ elevation. PKC activation was accomplished using the phorbol ester TPA. Free G␤␥ (G-protein ␤␥-subunits) were introduced by transient expression of G␤ 1 -and G␥ 2 -subunits and G␣ s was targeted using CTx, which irreversibly activates G␣ s , and prostaglandin E 1 , which activates G s via some endogenous prostanoid receptors. Also the exogenous adenylyl cyclase activator forskolin was included in the investigations. Under basal conditions, G s stimuli, i.e. via prostaglandin E 1 and CTx, and forskolin most strongly elevated cAMP (Fig. 2, A and B) . PKC, activated via TPA, stimulated cAMP production weakly in the control cells ( Fig. 2A) and somewhat more strongly in the presence of G s stimuli (CTx) (Fig. 2C) . No response to Ca 2ϩ elevation (thapsigargin and ionomycin) was seen under basal conditions ( Fig. 2A) or after CTx treatment (Fig. 2B) . Overexpression of G␤ 1 ␥ 2 subunits did not elevate cAMP level under basal conditions ( Fig. 2A) , but there was a weak, although nonsignificant elevation in the CTx-pretreated cells (Fig. 2C) .
RESULTS

Stimulatory Coupling of OX
The elevation caused by orexin-A was concentration-dependent with a pEC 50 of 6.51 Ϯ 0.03 (EC 50 ϭ 309 nM; number of independent experiments ϭ 5) (Fig. 3, filled circles) . Orexin-B also elevated cAMP with only a somewhat lower potency (pEC 50 ϭ 6.31 Ϯ 0.04 (EC 50 ϭ 490 nM); number of independent experiments ϭ 3) (Fig. 3, filled triangles) . Hence, orexin-B was almost equipotent to orexin-A (1.6-fold difference in the EC 50 ) in contrast to the previous studies with respect to the binding affinity and the potency for Ca 2ϩ elevation, where 10-fold difference has been seen (see Introduction and Discussion; Fig. 3 , open symbols). The potency of both peptides to elevate cAMP was much lower than their potency for other responses seen in CHO cells, such as Ca 2ϩ elevation (Fig. 3 , open symbols) and inositol phosphate mobilization (14) .
We then focused on the mechanism of adenylyl cyclase stimulation by orexin receptors. The data in Fig. 2 on the regulation of adenylyl cyclase in these cells show that of the classical adenylyl cyclase stimulators (G␣ s , G␤␥-subunits, Ca 2ϩ , and PKC) only G␣ s and PKC are active under basal conditions, but with simultaneous G␣ s activation, possibly even G␤␥ can elevate cAMP. In CTx-pretreated cells, orexin-A could still increase cAMP production, although the maximum response, as evaluated in fold activation, was clearly reduced (1.9 Ϯ 0.1 times the control, number of independent measurements ϭ 11; compare with 4.3 Ϯ 0.5 times in the absence of CTx). To ensure that the orexin-stimulated cAMP elevation in the CTx-treated cells was not due to residual G␣ s activity, a concentration response relationship was established for CTx stimulation of adenylyl cyclase (Fig. 4) . Already at 10 ng/ml CTx for 18 h, the adenylyl cyclase was apparently fully saturated with active G␣ s because higher concentrations of CTx did not produce any further increase in cAMP accumulation (Fig. 4) . 10 ng/ml probably does not activate all the G s proteins in the cells, but this apparently is enough to fully saturate adenylyl cyclase because there likely are several orders of magnitude fewer adenylyl cyclase molecules than there are G s -proteins (41, 42) . It thus appears likely that the response to orexin-A in CTx-pretreated cells cannot be dependent on activation of G s but must require some other messenger. We performed all the further experiments with 10 ng/ml CTx to avoid possible detrimental effects to the cells by higher CTx concentrations.
As previously shown in Fig. 2 , activation of PKC with TPA stimulates cAMP production in the presence of activated G s (CTx). This is further stimulated by Ca 2ϩ elevation using thapsigargin (Fig. 5A) , although thapsigargin by itself does not stimulate adenylyl cyclase in the presence or absence of G␣ sstimulation (Figs. 2, A and C, and 5A ). This suggests that at least the Ca 2ϩ -sensitive, conventional PKC isoforms might be involved in this response. The sensitivity of the TPA-mediated stimulation and combined TPA and thapsigargin-mediated stimulation was therefore tested for sensitivity to two different PKC inhibitors, Gö6976 and GF109203X. These two PKC inhibitors show some specificity for the three PKC families. Gö6976 essentially only inhibits conventional PKC isoforms (43) . TPA-stimulated cAMP elevation was not inhibited by Gö6976 at concentrations up to 10 M, but the Ca 2ϩ elevationdependent part of the response was inhibited in a concentration-dependent manner (Fig. 5B, ϩTPAϩthapsigargin) . GF109203X inhibits both conventional and novel PKC isoforms (1 M thapsigargin (thaps), 1 M ionomycin (io)), PKC (2 M TPA), G␤ 1 ␥ 2 (G␤␥), G␣ s (10 M prostaglandin E 1 , 10 ng/ml CTx), and forskolin (10 M) were evaluated. The other compounds were added to the cells at the start of the experiments, but G␤ 1 and G␥ 2 were expressed from plasmids introduced 48 h earlier, and the CTx pretreatment time was 18 h. In A and B, the effects of the treatments are evaluated on the basal level, and in C, the effects were evaluated in cells pretreated with CTx. There are no error bars in the bars indicating basal/control levels because the data from different batches of cells were normalized to the resting cAMP levels in the absence (basal; A and B) and presence (ctrl; C) of CTx. The comparisons are with the basal/control levels. and at higher concentrations even the atypical PKC (43) . In agreement with this, GF109203X inhibited both the TPA-and TPAϩthapsigargin-stimulated adenylyl cyclase activity with equal potency (Fig. 5C) . Thus, for some reason, TPA does basally only stimulate the novel, i.e. diacylglycerol-stimulated but not Ca 2ϩ -stimulated, PKC isoforms. OX 1 receptors are known to strongly and with high potency activate PLC and elevate Ca 2ϩ in CHO cells (14) , and therefore PKC activation would be a likely way for them to activate adenylyl cyclase in the presence of activated G␣ s . The effectivity of the PKC inhibitors was thus evaluated with respect to the orexin-A-induced cAMP elevation in the presence of G␣ s -stimulation. GF109203X fully and concentration-dependently inhibited the cAMP elevation caused by stimulation of orexin receptors in the CTx-treated cells (Fig. 5D ). In contrast, Gö6976 was completely ineffective at the concentrations up to 10 M (Fig. 5D) . Thus, in the presence of activated G s , adenylyl cyclase stimulation via OX 1 receptors appears to fully rely on some novel PKC isoform(s). The fact that no conventional PKC isoforms appear to be involved is somewhat surprising considering that OX 1 receptor stimulation strongly elevates intracellular Ca 2ϩ level. We further wanted to investigate the activation pathway for PKC. In agreement with our previous study (14) , OX 1 receptors strongly activated PLC in CHO cells, as assessed using biochemical measurement of total inositol phosphate generation (Fig. 6A) and measurement of translocation of GFP-labeled PKC␦ or -⑀ (only GFP-PKC⑀ shown in Fig. 6B ), which should be a measure of diacylglycerol generation. Release of diacylglycerol by PLC (likely the ␤ isoform) could thus make a plausible signal pathway for OX 1 receptor signaling to novel PKC. In agreement with this, U-73122, inhibitor of the phosphatidylinositol-specific phospholipase C, concentration-dependently inhibited orexin-A-induced cAMP accumulation (IC 50 ϭ Ϸ3 M; Fig. 6C ). The inhibition occurred at similar potency as the inhibition of PLC (IC 50 ϭ Ϸ1.5 M) and appears specific because U-73122 did not inhibit TPA-mediated adenylyl cyclase activation (not shown). Orexin receptors have also been suggested to signal via phosphatidylcholine-specific phospholipase C. This suggestion is based on the inhibitory effect of D609 (see e.g. Ref. 17 ), a putative inhibitor of this enzyme. However, we did not observe any inhibition with D609 (10 M, 30 min; Fig.  6C ). Phosphorylation of PKC by 3-phosphoinositide-dependent kinase 1 (PDK1) seems to be essential for the ability of PKC to be activated. 3-Phosphoinositide-dependent kinase 1 is activated upon phosphoinositide 3-kinase-dependent production of phosphatidylinositol-3,4,5-trisphosphate, and some of our data in CHO cells suggest that phosphoinositide 3-kinase is activated upon OX 1 receptor stimulation. 2 We therefore treated the cells with the phosphoinositide 3-kinase inhibitor wortmannin (100 nM, 30 min) prior to orexin stimulation. This did not affect the orexin-induced cAMP elevation. Altogether, the data with the inhibitors and direct measurements of inositol phosphate and diacylglycerol liberation suggest that orexin receptor signaling to novel PKC relies on activation of the classical phosphatidylinositol-specific phospholipase C.
We wanted to more specifically identify the novel PKC isoform involved in the OX 1 receptor stimulation of adenylyl cyclase. The novel class of PKC contains PKC␦, PKC⑀, PKC, and PKC. CHO cells have previously been suggested to express both PKC␦ and PKC⑀ (44) . In agreement with this, we could detect the presence of PKC␦ and -⑀ but not PKC or PKC in Western blot (Fig. 6D) . As expected, TPA pretreatment (2 M, 24 h) led to a partial down-regulation of both PKC␦ and PKC⑀ (Fig. 6D) . We applied specific inhibitors of each expressed isoform, rottlerin for PKC␦ (45) and KIE1-1 for PKC⑀ (34, 35) , and measured cAMP generation in the CTx-treated cells. Rottlerin (30 min of preincubation) produced a concentration-dependent (IC 50 ϭ Ϸ3.5 M) inhibition of orexin-A-induced cAMP accumulation (Fig. 6E) . In contrast, KIE1-1 (1 M, 30 min of preincubation) had no effect on orexin-A-mediated cAMP elevation (Fig. 6E) , although this concentration fully inhibited orexin-Ainduced translocation of GFP-PKC⑀ from the cytosol to the plasma membrane (data not shown). Thus, the data suggests that only PKC␦ is involved in the orexin response to adenylyl cyclase.
PLC is activated by OX 1 receptors at relatively high potency (EC 50 ϭ 1.5-15 nM, depending on the method used; Ref. 14; see also Fig. 6A ), which suggests that PKC activation should be of similar potency. This was indeed true; when the potency of orexin-A to stimulate adenylyl cyclase in CTx-treated cells was investigated, it was shown to be very similar to PLC activation (pEC 50 ϭ 8.06 Ϯ 0.14 (EC 50 ϭ 8.78 nM); number of independent measurements ϭ 8) (Fig. 7A, circles) . Thus, orexin-A was ϳ35-fold more potent in CTx-treated cells than in control cells. Orexin-B was also more potent in the CTx-treated than in nontreated cells (pEC 50 ϭ 6.99 Ϯ 0.15 (EC 50 ϭ 103 nM); number of independent measurements ϭ 3) (Fig. 7A, triangles) , although the difference was only 5-fold. This leads to more than 10-fold higher potency of orexin-A than orexin-B in CTxtreated cells. Thus, in CTx-treated cells, both the absolute and relative potencies of both orexin-A and -B were very similar to those observed for instance for Ca 2ϩ elevations (Fig. 3, open  symbols) .
The ability of simultaneous G s stimulation to increase the potency of OX 1 receptor signaling to adenylyl cyclase was further verified using transiently expressed ␤ 2 -adrenoceptors. Stimulation of these receptors with isoproterenol caused a very strong cAMP elevation ( Fig. 7B; 10 .1 Ϯ 1.7-fold; number of independent measurements ϭ 4). In the presence of isoproterenol, orexin concentration response curve was shifted to the left, putatively even more strongly than with CTx treatment (Fig. 7C) .
In the cells where adenylyl cyclase is maximally stimulated with G␣ s , OX 1 receptor signaling to adenylyl cyclase is thus entirely a result of activation of PKC␦. However, we have in Fig. 2A shown that the PKC activator TPA only very weakly stimulates adenylyl cyclase under basal conditions, i.e. in the absence of activated G␣ s . Thus, it appears unlikely that OX 1 receptor signaling to adenylyl cyclase under basal conditions would fully rely on PKC. In agreement with this logic, the PKC inhibitor GF109203X, but not Gö6976, reduced the orexin-Astimulated cAMP elevation maximally by about 60% under basal conditions (Fig. 8) . Both the PKC␦ inhibitor rottlerin and the PLC inhibitor U-73122 inhibited orexin-A-induced cAMP elevation in the same degree as GF109203X (Fig. 8) .
Based on the low activity of TPA ( Fig. 2A) and from the incomplete inhibitory effect of GF109203X on orexin-A signal (above) in non-CTx-treated cells, it appears likely that OX 1 receptor stimulation also generates some other signal that enhances the ability of activated PKC to activate adenylyl cyclase. Because we have shown that the adenylyl cyclase isoform(s) expressed in CHO cells are not Ca 2ϩ -sensitive (Fig.  2) , two possible signals are left, G␤␥ and G␣ s . An effect mediated by G␤␥ appears unlikely because overexpression of G␤ 1 ␥ 2 -subunits was found to have no effect on cAMP production in the absence of simultaneous G s stimulation ( Fig. 2A ) However, we further wanted to verify this by expressing G␤␥ scavengers. The use of G␤␥ scavengers may be tricky; low expression levels of the scavengers produce no inhibition, whereas higher levels can be toxic to the cells (own observation). This latter was also found to be the case in this study (data not shown). To find an expression level high enough to be fully active but still not toxic, several ␤␥ scavengers were tested for their ability to inhibit the signal in a paradigm generally accepted to rely on G␤␥ signaling, ␣ 2A -adrenoreceptor-induced Ca 2ϩ elevations (via G␤␥-mediated PLC activation). The cells were thus transiently transfected with the different constructs as described under "Ca 2ϩ Measurements." The only G␤␥ scavenger that had an inhibitory effect on this signal in our hands was transducin, which inhibited the UK14,304 (a selective ␣ 2 -adrenoreceptor agonist)-induced Ca 2ϩ signal by about 50% upon overexpression, which is the effectivity often seen in other studies with G␤␥ scavengers (46, 47) . Having established the effectiveness of this scavenger, we examined its effects on cAMP signaling in our cells. No effect on orexin-induced cAMP elevation in cells under basal conditions or pretreated with CTx could be seen (Fig. 9) ; we thus conclude that G␤␥-subunits are unlikely to mediate orexin-induced cAMP elevation. Thus, by elimination, G s coupling should explain the other component in orexin-stimulated cAMP elevation. The involvement of any G-protein in a given response can most reliably be proven using blocking antibodies. However, for the antibodies to be active they will have to access the cytosolic side of the cells. We therefore went over to cAMP measurements in permeabilized cells instead. We first characterized adenylyl cyclase signaling in this system. Both OX 1 receptors and ␤ 2 -adrenoceptors as well as forskolin-stimulated adenylyl cyclase activity in permeabilized cells (Fig. 10A) . However, the responses were much smaller than in intact cells (compare with Figs. 1, 2B, and 7B) , which is regularly seen when adenylyl cyclase activity in permeabilized cells/membranes is investigated (48, 49) . In contrast to the intact cells, ␤ 2 -adrenoreceptor and OX 1 receptors responses were not additive or synergistic ( Fig. 10A; compare with Fig. 7C ).
Anti-G␣ s antibodies inhibited ␤ 2 -adrenoreceptor-mediated (10 nM isoproterenol) adenylyl cyclase activity by ϳ50% (Fig.  10B) . Inhibition of this degree can usually be expected with G s -coupled receptors (48, 50) . OX 1 receptor-stimulated adenylyl cyclase activity was inhibited to the same extent as the ␤ 2 -adrenoreceptor-stimulated (Fig. 10B) , strongly indicating that OX 1 receptors also signal by activating G s . The specificity of the antibody-mediated inhibition is emphasized by their inability to attenuate forskolin-stimulated signaling (Fig. 10B) . Interestingly, the potency of orexin-A to stimulate adenylyl cyclase activity in permeabilized cells (Fig. 10C) was very similar to its ability to stimulate cAMP accumulation in intact cells in the absence of activated G␣ s (compare with Fig. 3 ). We also observed that GF109203X was not able to inhibit orexin-stimulated adenylyl cyclase activity in permeabilized cells (data not shown). This together with the fact that no OX 1 receptor response was seen in the presence of ␤ 2 -adrenoreceptor stimulus suggests that the PKC isoforms involved in OX 1 receptor signaling to adenylyl cyclase are not present or active in permeabilized cells.
Inhibitory Coupling of OX 1 Receptors to Adenylyl Cyclase-A thorough analysis of OX 1 receptor regulation of adenylyl cyclase showed that in addition to the stimulatory components characterized above, it also incorporated an inhibitory component. This was seen as an inhibition of the basal cAMP production at low orexin concentrations (by 21 Ϯ 5%, number of independent measurements ϭ 5) in non-CTx-treated cells (Fig.  11, filled circles) . This component was abolished when the cells were preincubated with pertussis toxin (Fig. 11, open circles) . The inhibition of cAMP generation is most likely due to the action of G␣ i (or G␣ o ; see Ref. 32) , because G␤␥-subunits did not appear to have any effect on orexin receptor regulation of adenylyl cyclase (Figs. 2 and 9 ). The inhibitory component was not seen in the CTx-treated cells, most likely because the potency of the inhibitory and stimulatory components overlapped (data not shown) DISCUSSION In this study we demonstrate that OX 1 orexin receptors affect adenylyl cyclase activity in CHO cells both positively and negatively. For the stimulatory effect, the data speak for a high efficacy coupling to PKC via the PLC pathway and for a low efficacy coupling to G s , which determines the overall potency of the response by being essentially permissive for the PKC effect. The inhibitory signal is more difficult to see because of the strong stimulatory coupling, but this response is of very high potency. In contrast to the stimulatory coupling, the inhibitory coupling is likely to be mediated by G i/o proteins.
As indicated in the Introduction, different adenylyl cyclase subtypes are distinguishable based on their specific regulatory All of the control data (white bars) were normalized to 100%, and the transducin data were normalized to its corresponding control, with which it also is compared.
inputs. The specific adenylyl cyclase expression profile of CHO cells is not known, but, as with all the cell types, they can be expected to express several isoforms. The basal testing suggests that Ca 2ϩ -stimulated isoforms AC1, AC3, and AC8 are not expressed in high amounts. In contrast, some PKC-stimulated isoforms, AC2, AC5, and AC7, are likely to be present. In agreement with previous studies in native cells and upon overexpression (32, 49, (51) (52) (53) , the effect of PKC on adenylyl cyclase was clearly enhanced by simultaneous G s activation. There possibly also was a small response to overexpression of G␤␥, suggesting that some isoform stimulated by G␤␥, AC2, AC4, or AC7, could be present, which is reasonable considering that AC2 and AC7 are also stimulated by PKC. It may be difficult to make conclusions of the effects of exogenous G␤␥ because there might be compensatory mechanisms activated by the long term G␤␥ elevation (coexpression), and the overexpression of G␤ 1 ␥ 2 might distort the signaling of G-proteins. Yet what seems clear is that G␤␥ are not important for the OX 1 receptor stimulation of adenylyl cyclase. Instead, the results most strongly suggest that adenylyl cyclase stimulation via OX 1 receptors occurs via G s and protein kinase C, apparently the novel ␦-isoform, in a manner where G s is essentially permissive for the PKC effect. For G s to be permissive for the PKC effect, it should act on the same adenylyl cyclase molecule as PKC. Therefore, it appears that the different stimulatory signals from the OX 1 receptor in most part target a single adenylyl cyclase isoform or a few isoforms with apparently similar regulatory properties.
The data suggest that PKC coupling of OX 1 receptors occurs via activation of PLC. In the light of the previous direct (10) and indirect data (14, 54) , it appears thus likely that this is a result of "the classical" G q 3 PLC␤ pathway. This is in agreement with our recent data showing high affinity interaction between OX 1 receptors and G q/11 .
3 Although this pathway would suggest rather nonselective signaling to different PKC via diacylglycerol and Ca 2ϩ , we could see that only novel PKC, in particular PKC␦, and not conventional PKC were involved in the OX 1 receptor stimulation of adenylyl cyclase activity. In a similar manner, the basal response to the diacylglycerol mimetic TPA in the presence of activated G s seemed to be mediated by novel PKC, but the response could be further stimulated by Ca 2ϩ elevations (thapsigargin) via a conventional PKCdependent manner. The latter condition should apparently simulate OX 1 receptor stimulation, which leads to diacylglycerol and inositol 1,4,5-trisphosphate release via PLC and Ca 2ϩ elevation via receptor-and store-operated Ca 2ϩ influx and inositol 1,4,5-trisphosphate-dependent Ca 2ϩ release (14, 20) . However, no involvement of conventional PKC could be seen in the orexin response, although the Ca 2ϩ elevation is even larger than that induced by thapsigargin. The reason for this can only be speculated. One possible explanation would be that orexin receptors, PLC, and particularly PKC (and adenylyl cyclase) somehow congregate with each other. In contrast, TPA causes a general (nonlocalized) PKC stimulation.
In this study we performed cAMP measurements both in intact cells and in permeabilized cells. Intact cells are a method of choice, but permeabilization allowed us to manipulate the intracellular side of the cells. We decided to use permeabilized cells instead of membrane preparations because this appeared to be more gentle for the cells, seen as better responses. The use of permeabilized cells confirmed the hypothesis of a direct activation of G s by OX 1 receptors and also the fact that this component determines the potency of the cAMP elevation in the absence of other G s stimulus. However, we also saw that the PKC dependence of the OX 1 receptor-mediated regulation of adenylyl cyclase vanished upon permeabilization of the cells. In some studies, PKC-dependent regulation of adenylyl cyclase activity is retained in membrane preparations. However, the stimulatory responses to adenylyl cyclase are in general strongly reduced by cell permeabilization/membrane preparation (48 -50) . This holds true for PKC-stimulated adenylyl cyclase activity; AC2, heterologously expressed in DDT 1 -MF2 cells, is stimulated by 172% in intact cell, whereas the stimulation is only 29% in the membranes (49) . If PKC activity is reduced upon cell permeabilization, the rather modest ability of PKC to stimulate adenylyl cyclase activity in our CHO cells is probably reduced significantly enough to be undetectable.
In the present study we observed an interesting difference in the ability of orexins to elevate cAMP in the absence and in the presence of activated G s (CTx or ␤ 2 -adrenoreceptor activation). Both orexins were markedly more potent in the presence of activated G s , and in permeabilized cells, where no PKC effect on adenylyl cyclase was seen, the potency of orexin-A was low. This led to the hypothesis, supported by other data, that the coupling of OX 1 receptors to phospholipase C is of high efficacy and to G s is of low efficacy. In the presence of activated G s , a typical 10-fold higher potency of orexin-A than orexin-B (see Introduction) was observed. This is logical in the light of the FIG. 10 . Adenylyl cyclase activity in permeabilized CHO cells. A, stimulation of adenylyl cyclase activity by different compounds. The first comparison is with the basal activity and the second to the to 1 M isoproterenol alone. B, the effect of the anti-G␣ s IgG on the stimulated adenylyl cyclase activity. The antibody data (black bars) are normalized to the corresponding controls in the absence of the antibody (white bars), with which they also are compared. C, concentration response curve for orexin-A. ctrl, control.
FIG. 11.
The effect of pertussis toxin on the cAMP production stimulated by orexin-A in intact CHO cells. Because there was no large difference in the basal or maximum stimulated levels in control (filled circles) or pertussis toxin-pretreated cells (empty circles), the data were normalized to same basal and maximum levels to better visualize the effect of pertussis toxin (PTx).
fact that this response is fully dependent on the activation of PKC, which occurs via PLC. The much lower potency observed in the absence of activated G s is in the light of the present study fully determined by the low efficacy coupling of OX 1 receptors to G s , because the high efficacy coupling to PKC cannot alone stimulate adenylyl cyclase. Most interestingly, there was only a 2-fold difference in the potency of orexin-A and -B peptides in the absence of activated G s . Thus, one important conclusion of this study is that OX 1 receptors do not have to strongly prefer orexin-A over orexin-B, as commonly thought (see Introduction), and the use of orexin-A and -B in pharmacological distinction of orexin receptor subtypes should be discouraged.
In one previous study, OX 1 and OX 2 receptor coupling to adenylyl cyclase regulation has been investigated in recombinant BIM cells (8) . In this study, surprisingly, none of the receptors stimulated cAMP production, and only OX 2 receptor was able to inhibit forskolin-stimulated adenylyl cyclase activity in a pertussis toxin-sensitive manner. This is in sharp contrast to the findings of the present study. As OX 1 receptors couple to G s they should be able to elevate cAMP in all the cells types, because all the membrane bound adenylyl cyclase isoforms respond to G␣ s . Also, we can clearly see a coupling of OX 1 receptors to pertussis toxin-sensitive inhibition of adenylyl cyclase. It is possible that this difference between our results and the results of Zhu et al. (8) is caused by the lack of expression of some particular G i/o isoform in BIM cells. However, it is rather clear that the results of Zhu et al. (8) do not represent any general difference between orexin receptor subtypes.
In conclusion, we have in this study shown that OX 1 orexin receptors couple to at least three different signal pathways to regulate adenylyl cyclase activity: 1) G i/o to inhibit cAMP generation, 2) G s to stimulate cAMP generation, and 3) PKC (via PLC and, putatively, G q ) to stimulate cAMP generation. This is the first demonstration of the functional significance of the previously suggested G s coupling (for the OX 2 receptor; Ref. 10 ). This coupling may be able to explain the orexin-stimulated cAMP accumulation and glucocorticoid synthesis in the adrenal cortex, which is unlikely to occur via Ca 2ϩ -or PKC-stimulated adenylyl cyclases (27, 55, 56) . The general of role of adenylyl cyclase in orexin receptor signaling is speculative, because almost no studies have addressed this question. However, because orexin receptors can connect to G s , they should have a principle ability to produce some adenylyl cyclase activation in all cell types, something that might be further regulated via the effect of Ca 2ϩ and PKC on specific adenylyl cyclase isoforms. Therefore, it appears likely that cAMP is a signal of importance for orexin receptors. On the pharmacological side, the results of the present study also demonstrate that the OX 1 receptor does not have to display any absolute selectivity between orexin-A and -B. 
